User profiles for John Burn

John Burn

Professor of Clinical Genetics
Verified email at ncl.ac.uk
Cited by 42451

[HTML][HTML] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein… - The Lancet, 2011 - thelancet.com
Background Observational studies report reduced colorectal cancer in regular aspirin
consumers. Randomised controlled trials have shown reduced risk of adenomas but none have …

Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project

J Burn, M Dennis, J Bamford, P Sandercock, D Wade… - Bmj, 1997 - bmj.com
Objective: To describe the immediate and long term risk of epileptic seizures after a first ever
stroke. Design: Cohort study following up stroke survivors for 2 to 6.5 years; comparison …

Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.

J Burn, M Dennis, J Bamford, P Sandercock, D Wade… - Stroke, 1994 - Am Heart Assoc
There have been few community-based studies of long-term prognosis after acute stroke.
This study aims to provide precise estimates of the absolute and relative risks of stroke …

[HTML][HTML] Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome

J Burn, DT Bishop, JP Mecklin, F Macrae… - … England Journal of …, 2008 - Mass Medical Soc
Background Observational and epidemiologic data indicate that the use of aspirin reduces
the risk of colorectal neoplasia; however, the effects of aspirin in the Lynch syndrome (…

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

…, WA Barker, AF Markham, D Bates, A Curtis, J Burn - Nature …, 2001 - nature.com
We describe here a previously unknown, dominantly inherited, late-onset basal ganglia
disease, variably presenting with extrapyramidal features similar to those of Huntington's …

[HTML][HTML] Celecoxib for the prevention of sporadic colorectal adenomas

…, JL Viner, D Bagheri, J Burn… - … England Journal of …, 2006 - Mass Medical Soc
Background Studies showing that drugs that inhibit cyclooxygenase-2 (COX-2) reduce the
number of colorectal adenomas in animals and patients with familial adenomatous polyposis …

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double …

J Burn, H Sheth, F Elliott, L Reed, F Macrae, JP Mecklin… - The Lancet, 2020 - thelancet.com
Background Lynch syndrome is associated with an increased risk of colorectal cancer and
with a broader spectrum of cancers, especially endometrial cancer. In 2011, our group …

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

J Cuzick, F Otto, JA Baron, PH Brown, J Burn… - The lancet …, 2009 - thelancet.com
Evidence clearly shows a chemopreventive effect for aspirin and other non-steroidal anti-inflammatory
drugs (NSAIDs) on colorectal cancer and probably other cancer types; however, …

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

…, A Alonso, S Aretz, I Bernstein, L Bertario, J Burn… - Gut, 2013 - gut.bmj.com
Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial
cancer and various other cancers, and is caused by a mutation in one of the mismatch repair …

Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

…, DV Parums, T Jowett, DA Marchuk, J Burn… - Developmental …, 2000 - Elsevier
Endoglin (CD105) is expressed on the surface of endothelial and haematopoietic cells in
mammals and binds TGFβ isoforms 1 and 3 in combination with the signaling complex of TGFβ …